Prevention Treatment Recovery

Using Naloxone to Reverse Opioid Overdose in the Workplace: Information for Employers and Workers

The National Institute for Occupational Safety and Health (NIOSH) developed this information to help employers and workers understand the risk of opioid overdose and help them decide if they should establish a workplace naloxone availability and use program.

Adolescent Community Reinforcement Approach (A-CRA)

The Adolescent Community Reinforcement Approach (A-CRA) is a developmentally appropriate treatment for youth and young adults (12-24 years old) with substance misuse or substance use disorders.  A-CRA is an evidence based treatment developed by Chestnut Health Systems.The brief treatment model can be delivered in outpatient clinics, community settings, homes, or school based settings and typically involves weekly sessions which can include parent(s) or caregivers.  Clinicians are trained and

National Library of Medicine's Opioid Resource List

The National Library of Medicine's Opioid Resource List provides regularly-updated links related to: 

  • Understanding Addiction
  • Opioid Overdose
  • Opioid Drugs
  • Medications to Treat Opioid Addiction
  • Opioid Prescribing
  • Pregnancy, Opioid use and NAS
  • Recovery; Data, Trends and Stats
  • NLM Resource searches

Office-Based Addiction Treatment (OBAT) Training and Technical Assistance (TTA) website

BMC and OBAT icons

Boston Medical Center’s Office Based Addiction Treatment (OBAT) Training and Technical Assistance (TTA) website offers a number of services. Visitors can learn about the OBAT Nurse Care Manager Model developed at Boston Medical Center (BMC), access free resources, and find out about the training and technical assistance offered by OBAT TTA to health care and social services providers looking to enhance their capacity to work with individuals with substance use disorders.

Maternal Opioid Use During Pregnancy Toolkit

This toolkit provides guidance in regards to the medical, psychological, and social needs of pregnant women with opioid use disorders, thereby improving maternal and newborn health outcomes. It has been developed to help maternal health providers advance the clinical interventions by offering screening, treatment engagement and coordinated care throughout the pregnancy and post-delivery.